Invitation to a debate on the serological criteria that define the antiphospholipid syndrome

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203 · see citing works

Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH.

Brandt, J. T., Triplett, D. A., Alving, B. M., & Scharrer, I. (1995) · PubMed · Cited by 1,164 · see citing works

Criteria for the Diagnosis of Lupus Anticoagulants: An Update: On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH

Brandt, J. T., Triplett, D. A., Alving, B., & Scharrer, I. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649901 · Cited by 993 · see citing works

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-02-0441 · Cited by 974 · see citing works

Lupus Anticoagulant IgG's (LA) Are Not Directed to Phospholipids only, but to a Complex of Lipid-Bound Human Prothrombin

Bevers, E. M., Galli, M., Barbui, T., Comfurius, P., & Zwaal, R. F. A. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646476 · Cited by 575 · see citing works

Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome

Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-11-3334 · Cited by 413 · see citing works

IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2–glycoprotein I cause LAC, and their presence correlates strongly with thrombosis

de Laat, B., Derksen, R. H. W. M., Urbanus, R. T., & de Groot, P. G. (2005) · Blood · doi:10.1182/blood-2004-09-3387 · Cited by 378 · see citing works

Untitled work

(2006) · PubMed · Cited by 248 · see citing works

β2-glycoprotein I–dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome

de Laat, H. B., Derksen, R. H. W. M., Urbanus, R. T., Roest, M., & de Groot, P. G. (2004) · Blood · doi:10.1182/blood-2004-03-1107 · Cited by 219 · see citing works

Anticardiolipin Antibody Assay: a Methodological Analysis for a better Consensus in Routine Determinations

Allegri, F., Sanmarco, M., Cinquini, M., Taglietti, M., Balestrieri, G., Koike, T., Ichikawa, K., Meroni, P. L., Boffa, M. C., & Tincani, A. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616089 · Cited by 182 · see citing works

Anticoagulant Activity of β2-Glycoprotein I Is Potentiated by a Distinct Subgroup of Anticardiolipin Antibodies

Galli, M., Comfurius, P., Barbui, T., Zwaal, R. F. A., & Bevers, E. M. (1992) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656368 · Cited by 174 · see citing works

Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study

Galli, M., Borrelli, G., Jacobsen, E. M., Marfisi, R. M., Finazzi, G., Marchioli, R., Wisloff, F., Marziali, S., Morboeuf, O., & Barbui, T. (2007) · Blood · doi:10.1182/blood-2007-01-066043 · Cited by 170 · see citing works

Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies

Tincani, A., Allegri, F., Balestrieri, G., Reber, G., Sanmarco, M., Meroni, P. L., & Boffa, M. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.06.035 · Cited by 128 · see citing works

Inter-laboratory variability of anti-beta2-glycoprotein I measurement. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group.

Reber, G., Schousboe, I., Tincani, A., Sanmarco, M., Kveder, T., de Moerloose, P., Boffa, M., & Arvieux, J. (2002) · PubMed · Cited by 119 · see citing works

Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus

Male, C., Foulon, D., Hoogendoorn, H., Vegh, P., Silverman, E., David, M., & Mitchell, L. (2005) · Blood · doi:10.1182/blood-2005-05-2048 · Cited by 106 · see citing works

Inter-laboratory Variability of Anti-β2-glycoprotein I Measurement

Schousboe, I., Tincani, A., Sanmarco, M., Kveder, T., de Moerloose, P., Boffa, M., Arvieux, J., & Reber, G. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613156 · Cited by 90 · see citing works

A simple method to discriminate between β2-glycoprotein I- and prothrombin-dependent lupus anticoagulants

Simmelink, M. J. A., Derksen, R. H. W. M., Arnout, J., & de Groot, P. G. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00146.x · Cited by 77 · see citing works

A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study)

NAESS, I. A., CHRISTIANSEN, S. C., CANNEGIETER, S. C., ROSENDAAL, F. R., & HAMMERSTROEM, J. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01691.x · Cited by 74 · see citing works

Anticardiolipin antibodies as a risk factor for venous thromboembolism in a population‐based prospective study

Runchey, S. S., Folsom, A. R., Tsai, M. Y., Cushman, M., & McGovern, P. D. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03949.x · Cited by 72 · see citing works

The contribution of anti-prothrombin-antibodies to lupus anticoagulant activity--discrimination between functional and non-functional anti-prothrombin-antibodies.

Horbach, D. A., van Oort, E., Derksen, R. H. W. M., & de Groot, P. G. (1998) · PubMed · Cited by 72 · see citing works

The Contribution of Anti-prothrombin-antibodies to Lupus Anticoagulant Activity

van Oort, E., Derksen, R. H. W. M., de Groot, P. G., & Horbach, D. A. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615066 · Cited by 71 · see citing works

A two‐step coagulation test to identify antiβ2‐glycoprotein I lupus anticoagulants

Pengo, V., Biasiolo, A., Pegoraro, C., & Iliceto, S. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00712.x · Cited by 70 · see citing works

Variability of anti-β2 glycoprotein I antibodies measurement by commercial assays

Tincani, A., Sanmarco, M., de Moerloose, P., Boffa, M., & Reber, G. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-02-0081 · Cited by 59 · see citing works

Variability of anti-beta2 glycoprotein I antibodies measurement by commercial assays.

Reber, G., Tincani, A., Sanmarco, M., et al. (2005) · PubMed · Cited by 55 · see citing works

Differences in functional activity of anticardiolipin antibodies from patients with syphilis and those with antiphospholipid syndrome

Pierangeli, S. S., Goldsmith, G. H., Krnic, S., & Harris, E. N. (1994) · Infection and Immunity · doi:10.1128/iai.62.9.4081-4084.1994 · Cited by 32 · see citing works

Untitled work

Wilson (1999) · doi:10.1002/1529-0131(199907)42:7

Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study

Urbanus, R. T., Siegerink, B., Roest, M., Rosendaal, F. R., de Groot, P. G., & Algra, A. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70239-x · Cited by 429 · see citing works

The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter study

DE LAAT, B., PENGO, V., PABINGER, I., MUSIAL, J., VOSKUYL, A. E., BULTINK, I. E. M., RUFFATTI, A., ROZMAN, B., KVEDER, T., DE MOERLOOSE, P., et al. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03588.x · Cited by 291 · see citing works

Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events

Otomo, K., Atsumi, T., Amengual, O., Fujieda, Y., Kato, M., Oku, K., Horita, T., Yasuda, S., & Koike, T. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33340 · Cited by 254 · see citing works

Diagnosis of antiphospholipid syndrome in routine clinical practice

Gardiner, C., Hills, J., Machin, S., & Cohen, H. (2013) · Lupus · doi:10.1177/0961203312460722 · Cited by 131 · see citing works

Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy

COHN, D. M., GODDIJN, M., MIDDELDORP, S., KOREVAAR, J. C., DAWOOD, F., & FARQUHARSON, R. G. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04015.x · Cited by 99 · see citing works

Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome

Devreese, K., & Hoylaerts, M. F. (2009) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2009.01243.x · Cited by 78 · see citing works

Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome

Persijn, L., Decavele, A.-S., Schouwers, S., & Devreese, K. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.04.004 · Cited by 53 · see citing works

Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus

Demir, S., Li, J., Magder, L. S., & Petri, M. (2021) · Rheumatology · doi:10.1093/rheumatology/keaa857 · Cited by 38 · see citing works

Number and sequence of preceding miscarriages and maternal age for the prediction of antiphospholipid syndrome in women with recurrent miscarriage

van den Boogaard, E., Cohn, D. M., Korevaar, J. C., Dawood, F., Vissenberg, R., Middeldorp, S., Goddijn, M., & Farquharson, R. G. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.09.002 · Cited by 36 · see citing works

Anticardiolipin and anti-β2glycoprotein-I antibody cut-off values in the diagnosis of antiphospholipid syndrome: more than calculating the in-house 99th percentiles, even for new automated assays

Devreese, K. M. J., & Van Hoecke, F. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.06.023 · Cited by 32 · see citing works

P48 Anti-beta 2-glycoprotein as compared with anticardiolipin antibody and lupus anticoagulant in diagnosis of antiphospholipid antibody syndrome

Sandhya, P., Prakash, J., Saritha, E., et al. (2008) · Indian Journal of Rheumatology · doi:10.1016/s0973-3698(10)60492-x

Prevalence of Anticardiolipin Antibodies in Pregnancies with History of Repeated Miscarriages

Spegiorin, L. C. J. F., Galão, E. A., Bagarelli, L. B., et al. (2010) · The Open Rheumatology Journal · doi:10.2174/1874312901004010028 · Cited by 12 · see citing works

Laboratory testing for antiphospholipid syndrome

Pengo, V., Banzato, A., Bison, E., Denas, G., Zoppellaro, G., Bracco, A., Jose, S. P., Hoxha, A., & Ruffatti, A. (2016) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12507 · Cited by 29 · see citing works

The clinical associations of lupus anticoagulant and anticardiolipin antibodies.

Chogle, A. R., & Buchanan, R. R. C. (1994) · PubMed

O22 Evaluation of anticardiolipin antibodies and lupus anticoagulant in healthy individuals and patients with thrombotic manifestations

Shraddha, A. P. M., Ls, B., Divate, S., et al. (2008) · Indian Journal of Rheumatology · doi:10.1016/s0973-3698(10)60396-2